Securities and Exchange Commission

Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent

Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.

Compare To Other Companies

Annual (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
-0.076	2015-02-27	10-K	2014	FY	2013-01-01	2013-12-31	CY2013
-0.132	2015-02-27	10-K	2014	FY	2014-01-01	2014-12-31	CY2014

All Reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
-0.076	2015-02-27	10-K	2014	FY	2013-01-01	2013-12-31	CY2013
-0.076	2014-03-03	10-K	2013	FY	2013-01-01	2013-12-31
-0.132	2015-02-27	10-K	2014	FY	2014-01-01	2014-12-31	CY2014